Literature DB >> 20811371

Deal watch: Harnessing creative risk sharing.

Tibor Papp.   

Abstract

Mesh:

Year:  2010        PMID: 20811371     DOI: 10.1038/nrd3257

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Deal watch: CureDM licenses regenerative diabetes therapy to Sanofi-Aventis.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

2.  Deal watch: Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.